---
title: "Librexia ACS trial of factor Xia inhibitor in ACS patients ended early"
date: "2025-11-18T12:50:12.000Z"
publishedDate: "18 novembre 2025"
summary: "Bristol Myers Squibb and Johnson &#38; Johnson have announced the decision to stop the phase 3 Librexia ACS trial evaluating the efficacy and safety of milvexian when added to the standard of care (conventional antiplatelet therapy) for patients after a recent acute coronary syndrome (ACS) event. The decision to discontinue the trial follows a preplanned [&#8230;] The post Librexia ACS trial of factor Xia inhibitor in ACS patients ended early appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/librexia-acs-trial-of-factor-xia-inhibitor-in-acs-patients-ended-early/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-11-18-librexia-acs-trial-of-factor-xia-inhibitor-in-acs-patients-ended-early"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2023/06/Red-blood-cells-image-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/librexia-acs-trial-of-factor-xia-inhibitor-in-acs-patients-ended-early/"
---

![Librexia ACS trial of factor Xia inhibitor in ACS patients ended early](http://cardiovascularnews.com/wp-content/uploads/sites/14/2023/06/Red-blood-cells-image-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/librexia-acs-trial-of-factor-xia-inhibitor-in-acs-patients-ended-early/*

## L’essentiel

Bristol Myers Squibb and Johnson &#38; Johnson have announced the decision to stop the phase 3 Librexia ACS trial evaluating the efficacy and safety of milvexian when added to the standard of care (conventional antiplatelet therapy) for patients after a recent acute coronary syndrome (ACS) event. The decision to discontinue the trial follows a preplanned [&#8230;] The post Librexia ACS trial of factor Xia inhibitor in ACS patients ended early appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/librexia-acs-trial-of-factor-xia-inhibitor-in-acs-patients-ended-early/
